Comparing Lumigan vs Xalatan
| Lumigan (bimatoprost) | Xalatan (latanoprost) |
|
|---|
| Lumigan (bimatoprost) | Xalatan (latanoprost) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Lumigan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Xalatan may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Intraocular Hypertension
Popular comparisons
|
|||||||
| More about Lumigan (bimatoprost) | More about Xalatan (latanoprost) | ||||||||
| Ratings & Reviews | |||||||||
|
Lumigan has an average rating of 5.2 out of 10 from a total of 25 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 36% reported a negative effect. |
Xalatan has an average rating of 7.3 out of 10 from a total of 13 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Lumigan side effects |
View all Xalatan side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Xalatan prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other bimatoprost brands include: Durysta | Other latanoprost brands include: Iyuzeh, Xelpros | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
0.75 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 7 drugs are known to interact with Lumigan:
|
A total of 7 drugs are known to interact with Xalatan:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
March 16, 2001 |
June 05, 1996 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.